AdvanCell

Sign in
Organization banner, image 1 of 3
Organization banner, image 2 of 3
Organization banner, image 3 of 3

Open roles

  • AdvanCell logo
    US Site Quality Lead

    AdvanCell

    • Andover, MA
    • On-site · Senior
    • $175k–$250k
    Lever
    Posted 56d ago
  • AdvanCell logo
    US Director, Health Safety & Environment (HSE)

    AdvanCell

    • Andover, MA
    • On-site · Director / Executive
    • $175k–$240k
    Lever
    Posted 56d ago
  • AdvanCell logo
    Director, CMC – Radiopharmaceutical Process Development

    AdvanCell

    • Boston, MA
    • Hybrid · Director / Executive
    • $170k–$220k
    Lever
    Posted 68d ago
  • AdvanCell logo
    Associate Director, CMC – Analytical Development

    AdvanCell

    • Boston, MA
    • Hybrid · Director / Executive
    • $170k–$220k
    Lever
    Posted 68d ago
  • AdvanCell logo
    Director, CMC – Precursor Development & Manufacturing

    AdvanCell

    • Boston, MA
    • Hybrid · Director / Executive
    • $170k–$230k
    Lever
    Posted 68d ago
  • AdvanCell logo
    Associate Director, Trial Operations & Budget

    AdvanCell

    • Boston, MA
    • Hybrid · Director / Executive
    • $170k–$220k
    Lever
    Posted 103d ago

About

AdvanCell logo

AdvanCell

Changing the Course of Cancer Treatment

AdvanCell is a clinical stage radiopharmaceutical company developing an innovative pipeline of 212Pb-based Targeted Alpha Therapies for cancer patients. AdvanCell’s platform technology addresses the most significant challenge in Targeted Alpha Therapy – the reliable and scalable supply of isotope. AdvanCell’s novel drug discovery, preclinical processes, and state-of-the-art facilities leverage daily access to 212Pb, the ideal isotope for Targeted Alpha Therapy. For more information, please visit www.advancell.com.au

Private companySeries DIn the news
Founded2019
HQBoston, United States
Size51–200 employees
IndustryBiotechnology Research
Latest fundingSeries D · Jul 15, 2026
News
  • AdvanCell Names Andy Porter Chief People Officer
  • AdvanCell Appoints Andy Porter Chief People Officer, Martin Huber to Board of Directors
  • AdvanCell Strengthens Leadership with Appointment of Andy Porter as Chief People Officer and Martin Huber, M.D., to its Board of Directors
  • AdvanCell reports data on Pb-212 PSMA therapy

Claim advancell.com.au

Work at advancell.com.au? Sign in to claim this org and manage its profile.

ThesisExploreTermsPrivacy
© 2026 Saywise Inc.